Earnings Insights · DOW · Q3 FY2026

Dow Q3 2026 Earnings: Pricing and Self-Help Drive a Sharp Profit Recovery

By AlgovestIQ ResearchPublished

Share

Read Dow’s results announcement (Form 8-K, filed Oct 22, 2026)

Key earnings findings

Dow (DOW) Q3 FY2026 · results discussed on the earnings call · Form 8-K filed

  1. Dow reported Q3 FY2026 revenue of $11.27B against the $11.22B analyst estimate, a 0.4% beat, and EPS of $0.71 against the $0.64 analyst estimate, a 11.3% beat.
  2. Management expects fourth-quarter operating EBITDA of approximately $1.5B, roughly flat with the $1.6B reported in the third quarter.
  3. DOW closed at $31.81 on Oct 22, 2026, up 4.7% from $30.38 on Oct 21, 2026, the last close before the results were released.

Sources: Dow results announcement (SEC), the Q3 FY2026 earnings call, and AlgovestIQ reported-results and market data. All references

Did Dow beat earnings expectations?

Actual
Estimate
Surprise
Revenue
$11.27B
$11.22B
+0.4%
EPS
$0.71
$0.64
+11.3%
  • EPS has beaten the estimate in 5 of the most recent reported quarters.
  • Revenue surprise across the last 8 reported quarters has ranged from -2.4% to 1.9%.

Reported figures against analyst estimates, compiled from AlgovestIQ data.

Dow’s third-quarter results improved sharply from a weak year-ago period, with net sales rising 13% to $11.3B and GAAP EPS increasing to $0.62 from $0.08. Higher polyethylene and other product prices, combined with cost and portfolio actions, drove the recovery, while total volume still fell 1% as Middle East disruptions constrained Asia Pacific operations.

The central investment question is whether Dow can sustain higher polyethylene margins and convert its restructuring and transformation programs into durable earnings growth as volumes and global petrochemical utilization remain uneven.

Earnings Snapshot

MetricReportedChange
Net sales$11.3BUp 13% year over year
GAAP net income$525MUp from $124M
GAAP diluted EPS$0.62Up from $0.08
Operating EPS*$0.71Up from a loss of $0.19
Operating EBIT*$887MUp $707M
Operating EBITDA*$1.6BUp $685M
Cash from operating activities, continuing operations$1.8BUp $709M
Free cash flow*$1.1BUp from $566M
Packaging & Specialty Plastics sales$5.8BUp 18%
Packaging & Specialty Plastics operating EBIT*$585MUp $386M
Industrial Intermediates & Infrastructure sales$3.1BUp 8%
Industrial Intermediates & Infrastructure operating EBIT*$176MUp $223M
Performance Materials & Coatings sales$2.3BUp 8%
Performance Materials & Coatings operating EBIT*$154MUp $74M

\*Operating measures and free cash flow are non-GAAP measures.

The Bigger Story

Dow’s earnings recovery was driven more by price and self-help initiatives than by broad-based volume growth. Local price and product mix increased 14% year over year, more than offsetting a 1% decline in volume. Packaging & Specialty Plastics, Dow’s largest segment, accounted for more than two-thirds of the company’s year-over-year operating EBIT improvement.

Management is attempting to reshape Dow’s earnings base through cost reductions, European asset closures, workforce actions and targeted downstream investments. The company said its transformation program produced about $250M of benefits in the third quarter and roughly $450M year to date. It expects approximately $700M of growth and productivity improvements from the program in 2026.

That execution helped Dow offset higher raw-material and logistics costs. However, the quarter also showed the limits of the recovery: Asia Pacific sales declined 3%, with volume down 12%, as the Middle East conflict disrupted supply and logistics. Several Middle East joint-venture assets remain constrained or partially operating.

Revenue and Operating Performance

Net sales rose to $11.3B from $10.0B a year earlier. Price and mix added 14 percentage points to growth, currency was flat, and volume reduced sales growth by 1 percentage point.

The geographic pattern was uneven. Sales rose 18% in Europe, the Middle East, Africa and India, 16% in the U.S. and Canada, and 15% in Latin America. Asia Pacific was the exception, where sales fell 3% on a 12% volume decline. Management attributed the weakness primarily to supply constraints tied to the Middle East conflict.

Packaging & Specialty Plastics led the recovery

Packaging & Specialty Plastics sales increased 18% to $5.8B. Local prices rose 17%, while volume increased 1%. Higher polyethylene and functional polymer prices across all regions drove the gain.

Operating EBIT increased to $585M from $199M. Higher polyethylene prices, improved integrated margins and self-help benefits outweighed higher planned maintenance activity.

Management said polyethylene demand remained resilient, particularly in infrastructure-related pipe applications across EMEAI. The company also cited sequential volume gains and a restart of its Terneuzen cracker in Europe after planned maintenance, which supported higher olefins volumes and record European LPG consumption.

Still, reported volume growth understates the operational disruption elsewhere in the portfolio. Management said Packaging & Specialty Plastics volume would have increased 2% excluding Middle East-related supply constraints.

Industrial Intermediates returned to profit

Industrial Intermediates & Infrastructure sales rose 8% to $3.1B despite a 7% volume decline. Local prices rose 16%, reflecting gains across both business lines and all regions.

Operating EBIT improved to $176M from a $47M loss. Higher margins and self-help initiatives were important contributors, as was the suspension of recognition of equity losses from Sadara. That last item is significant because part of the segment’s year-over-year improvement came from the accounting treatment of its affiliate exposure, rather than solely from underlying operating demand.

Industrial Solutions delivered higher volumes, supported by AI infrastructure, energy applications and project-related ethylene oxide catalyst sales. In contrast, Polyurethanes & Construction Chemicals continued to face weaker construction demand and Middle East-related disruption.

Performance Materials & Coatings improved on both price and volume

Performance Materials & Coatings sales increased 8% to $2.3B, with local price up 5% and volume up 3%. Operating EBIT increased to $154M from $80M.

Downstream silicones supported Consumer Solutions, with volume gains in consumer, electronics and home-care applications. Coatings & Performance Monomers benefited from higher prices and volumes in acrylic monomers and architectural coatings.

The segment also benefited from the closure of Dow’s Barry, U.K., siloxanes facility. The closure removes higher-cost upstream capacity, although it also reflects the pressure created by substantial silicone capacity additions in China.

Profitability and Margins

Operating EBITDA increased to $1.6B from $868M, while operating EBIT rose to $887M from $180M. Operating EBIT margin was about 7.9%, compared with roughly 1.8% a year earlier.

The improvement reflected pricing, better integrated polyethylene margins and cost actions. Management said it generated more than $150M of sequential self-help benefits during the quarter, including cost savings, transformation actions and benefits from the Barry siloxanes shutdown. Those gains were largely offset by margin pressure during the quarter, particularly in Packaging & Specialty Plastics, after sharp price swings earlier in the year.

GAAP EPS was $0.62, while operating EPS was $0.71. The $0.09-per-share difference reflected net significant items, including $0.08 per share of Transform to Outperform costs, $0.03 per share of restructuring implementation costs and $0.06 per share from early debt extinguishment. Those charges were partly offset by a $0.08-per-share gain related to litigation.

The comparison with the prior year is also affected by significant items. Third-quarter 2025 GAAP EPS was positive at $0.08, but operating EPS was a loss of $0.19 after excluding divestiture gains and tax-related benefits. The adjusted comparison therefore provides a clearer view of the underlying recovery, though it should not obscure the company’s continuing restructuring costs.

Demand, Customers and Pricing

Dow’s demand outlook remains mixed by product chain and region.

Management described global packaging demand as resilient and cited continued strength in electronics, AI infrastructure, energy applications and electric vehicles. Downstream silicones, thermal-management materials and engineered products used in electronics and mobility remain areas of targeted growth investment.

Housing and construction remain the clearest weak point. Management expects normal fourth-quarter seasonal weakness in building and construction to reduce earnings in Industrial Intermediates & Infrastructure. It also expects MDI markets to become longer as supply disruptions ease and new North American capacity comes online.

Polyethylene pricing is central to the near-term outlook. Management expects global integrated polyethylene margins to improve by approximately $0.02 per pound sequentially in the fourth quarter, based on September price increases carrying through the full quarter. It also has polyethylene price increases of $0.07 per pound for October and $0.05 per pound for November on the table.

Management said full realization of those increases could create roughly $200M of upside to its fourth-quarter outlook, although that would depend on feedstock costs and market conditions. It estimated that each $0.01 per pound of polyethylene price increase represents about $50M per quarter.

The pricing environment is being supported by elevated oil and naphtha costs, trade-flow uncertainty and constrained supply in some regions. These factors can improve Dow’s near-term margins, but they also underscore that part of the current pricing strength is connected to disruption rather than purely demand-led market tightening.

What is Dow’s guidance for Q4 2026?

Management expects fourth-quarter operating EBITDA of approximately $1.5B, roughly flat with the $1.6B reported in the third quarter.

The outlook assumes that recent polyethylene price gains will improve margins before higher raw-material costs take effect. Management expects approximately $100M of lower sequential turnaround spending and another approximately $100M of sequential benefit from self-help actions, including its transformation program and the Barry facility closure.

In Packaging & Specialty Plastics, Dow expects global polyethylene integrated margins to improve by about $0.02 per pound sequentially. In the other two operating segments, management expects a typical seasonal slowdown in building and construction activity.

For 2027, management expects about $1.3B of self-help benefits, including approximately $1.2B from Transform to Outperform and roughly $100M from asset actions and growth investments. Management indicated that about half of the anticipated benefit would be in Packaging & Specialty Plastics, with about one-quarter in each of the other two operating segments.

Balance Sheet, Cash Flow and Capital

Cash from operating activities was $1.8B in the quarter, up $709M year over year and $515M sequentially. Free cash flow was $1.1B after $706M of capital expenditures.

The cash-flow result was aided by working-capital improvement. Management said it released more than $400M of working capital in the third quarter and remains on track for more than $500M of working-capital release in the second half of 2026. This supported a trailing-12-month cash-flow-conversion rate of 84%, though the quarterly cash result benefited materially from the working-capital swing.

Dow ended the quarter with $4.1B of cash and cash equivalents. Long-term debt was $16.8B, with another $745M due within one year. Management said it repurchased about $300M of debt in the third quarter and plans an additional roughly $200M in the fourth quarter. Together with a March 2027 Eurobond maturity, these actions are expected to retire approximately $1.4B of debt.

The company continues to fund its Path2Zero project in Alberta, Canada. Management said the project was about 45% complete, with the first phase expected at the end of 2029 and the second phase in 2030. Dow remains open to bringing in a partner, but said it is prepared to complete the project on its own if a transaction does not meet its return and value-creation thresholds.

What Investors Should Watch

1. Polyethylene price realization and margins

The fourth-quarter EBITDA outlook depends partly on higher polyethylene prices taking hold before higher feedstock costs pressure margins. The spread between realized price increases and ethane, naphtha and logistics costs will be a key measure of the durability of the recovery.

2. Volume recovery outside disrupted Middle East operations

Reported volume declined 1% in the quarter, and Asia Pacific volume fell 12%. Investors should watch whether Dow can restore constrained joint-venture production and translate management’s reported demand strength into sustained shipment growth.

3. Construction and polyurethane demand

Industrial Intermediates returned to profitability, but its construction-related businesses remain exposed to weak housing demand and new MDI capacity. A continued decline in volumes or pricing would limit the segment’s recovery.

4. Delivery of transformation savings

Management expects about $1.3B of self-help benefits in 2027. Progress in workforce reductions, manufacturing productivity, procurement and site efficiency will determine whether these benefits become durable earnings improvement rather than temporary cost deferral.

5. Cash conversion, debt reduction and Alberta execution

Working-capital releases supported third-quarter free cash flow. Investors should watch whether cash conversion remains in management’s targeted 70% to 80% range in 2027, while Dow continues deleveraging and funds the capital-intensive Alberta project.

AlgovestIQ Takeaway

Dow produced a substantially stronger quarter, led by pricing and an improvement in Packaging & Specialty Plastics. The company also demonstrated meaningful operating leverage: a 13% increase in sales produced a $707M increase in operating EBIT.

The recovery is not yet a broad volume-led upcycle. Companywide volume declined, Asia Pacific weakened sharply, and a portion of Industrial Intermediates’ profit improvement reflected the suspension of Sadara equity-loss recognition. Middle East-related disruptions have simultaneously constrained Dow’s volumes and supported pricing in some product chains.

Dow’s self-help program is becoming more important to the investment case. Management has identified sizable transformation and portfolio benefits for 2026 and 2027, and the third-quarter result showed evidence that those actions are reaching the income statement. The key test will be whether Dow can retain those gains when market conditions normalize.

The near-term setup depends heavily on polyethylene margins. If Dow realizes its October and November price initiatives while feedstock inflation remains manageable, fourth-quarter EBITDA could exceed the approximately $1.5B outlook. Conversely, a reversal in disruption-driven pricing, persistent weak construction demand, or further operational constraints in the Middle East would expose the limits of the current recovery.

For longer-term investors, the central question is whether Dow can combine its cost-reset program, downstream growth investments and North American feedstock advantage into a more stable earnings base before the Alberta project begins contributing at the end of the decade.

How did DOW stock react?

DOW closed at $31.81 on Oct 22, 2026, up 4.7% from $30.38 on Oct 21, 2026, the last close before the results were released.

SessionCloseChange
Oct 21, 2026 (before release)$30.38—
Oct 22, 2026$31.81+4.7%
Oct 23, 2026$32.61+7.3%

Closing prices from AlgovestIQ market data. A move around a report also reflects the wider market.

More from this earnings season

References

  1. Management commentary, analyst questions and outlook discussed on the call. Source: Dow Q3 FY2026 earnings call transcript, as of Oct 22, 2026.
  2. Reported results, segment figures and guidance from the company's results announcement. Source: Dow Form 8-K, Item 2.02 (SEC EDGAR), as of Oct 22, 2026.
  3. Reported revenue and EPS against analyst estimates, and the reported quarterly series. Source: AlgovestIQ reported-results data, as of Oct 22, 2026.

AI-generated analysis based on company-reported earnings data and earnings-call materials. Not investment advice.